Raymond James Reiterates Strong Buy Rating on ARS Pharmaceuticals Inc (SPRY)

November 10, 2025 7:28 AM

Raymond James analyst Ryan Deschner reiterated a Strong Buy rating and $32.00 price target on ARS Pharmaceuticals Inc (NASDAQ: SPRY).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found